logo

For the Inventor, By the Inventor

Berkeley, CA, United States of America

Judith M Segall

USPTO Granted Patents = 23

Average Co-Inventor Count = 4.0

ph-index = 10

Forward Citations = 578(Granted Patents)


Company Filing History:

goldMedal23 out of 35 
 
Biotime, Inc.
 patents

Years Active: 1995-2011

Loading Chart...
23 patents (USPTO):Explore Patents
1. 7943292 - Physiologically acceptable aqueous solutions and methods for their use (2011-05-17),
2. 6680305 - Physiologically acceptable aqueous solutions and methods for their use (2004-01-20),
3. 6627393 - Solutions for use as plasma expanders and substitutes (2003-09-30),
4. 6506549 - Plasma expanders and blood substitutes (2003-01-14),
5. 6444418 - Plasma-like solution (2002-09-03),
6. 6410218 - Plasma-like solution (2002-06-25),
7. 6406839 - Methods for using a plasma-like solution (2002-06-18),
8. 6387612 - Method of preparing a terminally heat sterilized plasma-like solution (2002-05-14),
9. 6300322 - Plasma-like solution (2001-10-09),
10. 6284452 - Methods of using plasma expanders and blood substitutes (2001-09-04),
11. 6218099 - Methods and compositions for use in perfusion applications (2001-04-17),
12. 6110504 - Plasma-like substance (2000-08-29),
13. 6080538 - Plasma like solution and methods of use (2000-06-27),
14. 5968726 - Plasma-like solution (1999-10-19),
15. 5945272 - Plasma expanders and blood substitutes (1999-08-31),

Title: Judith M. Segall: A Trailblazer in Physiological Solutions

Introduction

Judith M. Segall is a prominent inventor based in Berkeley, California, with an impressive portfolio of 23 patents. Her innovative contributions to the field of physiological solutions have made significant strides, particularly in the development of artificial plasma-like solutions designed to serve critical applications in healthcare.

Latest Patents

Among her latest patents, Segall has developed two key inventions that focus on physiologically acceptable aqueous solutions. The first patent details methods for creating artificial plasma-like solutions that include electrolytes and an oncotic agent, specifically aimed at applications requiring the replacement of a host's blood volume with a blood substitute. The second patent introduces a new formulation of physiologically acceptable aqueous solutions that comprises electrolytes and a dynamic buffering system, without conventional biological buffers, emphasizing its utility in similar blood substitute applications.

Career Highlights

Judith M. Segall's career is marked by her dedication to improving medical solutions that can enhance patient care. Her work at BioTime, Inc. has positioned her as a key figure in the innovation of substitutes for blood volume loss, a critical area in medical emergencies and surgeries.

Collaborations

Segall collaborates closely with esteemed colleagues, including Paul E. Segall and Harold D. Waitz, contributing to a dynamic work environment at BioTime, Inc. This collaborative spirit has enabled the advancement of her research and the successful deployment of her patented technologies.

Conclusion

Judith M. Segall stands out as an influential inventor whose work continues to impact the medical field significantly. With her innovative research focusing on artificial plasma solutions, she not only exemplifies the spirit of invention but also demonstrates the potential of medical advancements to improve lives. Her achievements reflect the importance of continuous innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…